pindolol has been researched along with Astasia-Abasia in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kelesidis, G | 1 |
Hagis, P | 1 |
Samaras, C | 1 |
1 trial available for pindolol and Astasia-Abasia
Article | Year |
---|---|
Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Conversion Disorder; Exercise | 1972 |